ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
66.876,79
-0,30%
Brent Oil
83,76
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Gamida Cell Ltd (GMDA)

  7. Gamida Cell Ltd (GMDA) Notícias

GMDA

Gamida Cell (GMDA)

Gamida Cell Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GMDA
DataHoraFonteTítuloCódigoCompanhia
08/04/202408:30GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:GMDAGamida Cell Ltd
01/04/202409:00GlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNASDAQ:GMDAGamida Cell Ltd
27/03/202407:57IH Market NewsU.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early TradingNASDAQ:GMDAGamida Cell Ltd
14/02/202416:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GMDAGamida Cell Ltd
02/02/202418:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GMDAGamida Cell Ltd
29/01/202408:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GMDAGamida Cell Ltd
15/12/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GMDAGamida Cell Ltd
06/12/202319:24Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:GMDAGamida Cell Ltd
20/11/202319:27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GMDAGamida Cell Ltd
15/11/202319:24Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GMDAGamida Cell Ltd
14/11/202309:00GlobeNewswire Inc.Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:GMDAGamida Cell Ltd
20/10/202317:39Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:GMDAGamida Cell Ltd
11/10/202308:07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GMDAGamida Cell Ltd
13/09/202317:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GMDAGamida Cell Ltd
01/09/202317:08Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GMDAGamida Cell Ltd
21/08/202318:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:GMDAGamida Cell Ltd
15/08/202317:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GMDAGamida Cell Ltd
14/08/202317:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GMDAGamida Cell Ltd
11/07/202309:00Business WireData Published in Transplantation and Cellular Therapy Suggest Antiviral Protection After Transplantation with Gamida Cell’s Omisirge® (omidubicel-onlv)NASDAQ:GMDAGamida Cell Ltd
10/07/202315:00PR Newswire (US)STAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE OFFICERNASDAQ:GMDAGamida Cell Ltd
14/06/202317:30Business WireGamida Cell To Host Investor DayNASDAQ:GMDAGamida Cell Ltd
31/05/202317:30Business WireGamida Cell to Present Corporate Highlights at the Jefferies Healthcare ConferenceNASDAQ:GMDAGamida Cell Ltd
31/05/202308:00Business WireData To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual MeetingNASDAQ:GMDAGamida Cell Ltd
26/05/202317:20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMDAGamida Cell Ltd
25/05/202317:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GMDAGamida Cell Ltd
22/05/202309:00Business WireGamida Cell Appoints Terry Coelho as CFONASDAQ:GMDAGamida Cell Ltd
16/05/202317:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GMDAGamida Cell Ltd
15/05/202318:14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GMDAGamida Cell Ltd
15/05/202317:05Business WireGamida Cell Reports First Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:GMDAGamida Cell Ltd
11/05/202318:20Business WireGamida Cell Announces the Date of Its First Quarter 2023 Financial Results and WebcastNASDAQ:GMDAGamida Cell Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:GMDA

Seu Histórico Recente

LSE
106H
BIT
UC5R48
Unicredit Bank
USOTC
GBCEY
Globe Trade Centre (CE)
NASDAQ
CDXS
Codexis
USOTC
BTPNF
Bank BTPN TBK PT (CE)
KUCN
WAXPETH
WAX Protocol Tokens
USOTC
PEASF
Global Food and Ingredie... (PK)
USOTC
GSEFF
Convivio (PK)
BIT
F14616
Vontobel Financial Produ...
EU
G089T
G089T
BIT
UB87QU
Unicredit Bank
BIT
F17488
Vontobel Financial Produ...
BIT
UC3T3K
Unicredit Bank
AMEX
RTS
CSE
AICO
Generative Al Solutions
LBNK
BZZUSDT
Bzz
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados